Astigmatism Global Market Report 2025

The astigmatism market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to increased screen time, a rising prevalence of myopia, advancements in diagnostic technology, broader access to eye care, and heightened awareness of vision correction.

The astigmatism market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period is expected to be driven by the increasing adoption of toric lenses, higher demand for laser eye surgery, a growing aging population, the rising prevalence of digital eye strain, and expanding healthcare infrastructure. Key trends during this period include advancements in AI-powered diagnostics, the adoption of premium toric intraocular lenses (IOLs), the development of non-invasive treatment options, progress in hybrid contact lens technology, and the growth of mobile eye care clinics.

The increasing prevalence of vision impairment is expected to drive growth in the astigmatism market in the coming years. Vision impairment refers to a condition where a person experiences partial or complete loss of sight that cannot be fully corrected with glasses, contact lenses, or medical treatment. This rise in vision impairment is influenced by factors such as an aging population, a growing number of cases of diabetes and eye diseases, excessive screen time, and limited access to eye care in certain regions. Astigmatism contributes to this condition by causing blurred or distorted vision, resulting from an irregular shape of the cornea or lens that interferes with the proper focus of light on the retina. For example, in December 2023, the United Nations Development Programme reported that the number of people diagnosed with vision impairments rose to 19,551 in 2022, up from 17,478 in 2021. Additionally, more than 19,000 new diagnoses were recorded in just the first seven months of 2023. As a result, the growing prevalence of vision impairment is contributing to the expansion of the astigmatism market.

Companies in the astigmatism market are focusing on developing new technologies to enhance contact lens comfort and improve vision quality for individuals with astigmatism. One such innovation is water gradient technology, which involves a design that gradually increases water content from the core to the surface of the lens, providing better moisture retention and comfort. For example, in January 2023, Alcon Inc., a Switzerland-based pharmaceutical and medical device company, introduced TOTAL30 for Astigmatism. This product is the first reusable contact lens made with Water Gradient material, specifically designed for people with astigmatism. Research indicates that comfort plays a significant role in both the wearing experience and customer loyalty.

In January 2024, STAAR Surgical Company, a US-based manufacturer and marketer of implantable lenses and companion delivery systems for the eye, partnered with Sharpe Vision to expand access to EVO ICL lenses. This partnership aims to jointly promote and raise awareness about the availability of EVO ICL lenses for eligible patients at Sharpe Vision clinics. STAAR Surgical will also offer clinical and practice development support. Sharpe Vision is a US-based company providing advanced vision correction services, including laser eye surgery for conditions such as nearsightedness, farsightedness, astigmatism, and presbyopia.

Major players in the astigmatism market are Johnson & Johnson Services Inc., Novartis AG, EssilorLuxottica SA, Alcon Inc., HOYA Corporation, Bausch + Lomb Incorporated, CooperVision Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Shamir Optical Industry Ltd., STAAR Surgical Company, Menicon Co. Ltd., Rayner Intraocular Lenses Limited, Ophtec BV, SEA VISION S.r.l., SynergEyes Inc., Contamac Ltd., SEED Co. Ltd., Miranza Clínica, and Visionary Optics LLC.

North America was the largest region in the astigmatism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in astigmatism report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the astigmatism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Astigmatism is a refractive error in the eye where the cornea or lens has an irregular shape, resulting in blurred or distorted vision. It happens when light entering the eye is not properly focused on the retina, making it difficult to see fine details at any distance.

The primary types of astigmatism include myopic astigmatism, hyperopic astigmatism, mixed astigmatism, and others. Myopic astigmatism is a refractive error where the cornea or lens is irregularly shaped, causing blurred vision for both near and far objects, with an added nearsightedness (myopia) component. Treatment options include corrective lenses, orthokeratology, surgeries, and others, with key end users including hospitals, clinics, and more.

The astigmatism market research report is one of a series of new reports that provides astigmatism market statistics, including the astigmatism industry global market size, regional shares, competitors with the astigmatism market share, detailed astigmatism market segments, market trends, and opportunities, and any further data you may need to thrive in the astigmatism industry. This astigmatism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The astigmatism market consists of revenues earned by entities by providing services such as refractive surgery, diagnostic services, and vision therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The astigmatism market also includes sales of eyeglasses and contact lenses, astigmatism-specific eye care products, surgical equipment, and optical devices and tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.